|
| | Issue Date | Title | Author(s) |
| 1 | 16-Dec-2025 | Exploiting artificial intelligence in precision oncology: an updated comprehensive review | Goda, Roaa Yousry; Abdel-Aziz, Amal Kamal |
| 2 | May-2025 | Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML | El-Deen, Nada Alaa; DeFilippis, RosaAnna; Milik, Sandra N; Patel, Suhana; Ismail, Muhammad I; Khaled, Omar; Ahmed, Tarek Erfan; Abdelfattah, Ayatullah Gamal; Ali, Eslam M H; Gaballah, Maiy Y; McPhillie, Martin J; Abouzid, Khaled A M; Henary, Maged; Minucci, Saverio; Shah, Neil P; Dokla, Eman M E; Abdel-Aziz, Amal Kamal ; Serya, Rabah |
| 3 | 2024 | Deciphering the Complex Interplay of Long Noncoding RNAs and Aurora Kinases: Novel Insights into Breast Cancer Development and Therapeutic Strategies | Saadeldin, Mona Kamal; Curigliano, Giuseppe; Abdel-Aziz, Amal Kamal |
| 4 | Nov-2023 | FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review | Abdel-Aziz, Amal Kamal ; Dokla, Eman M E; Saadeldin, Mona Kamal |
| 5 | Dec-2022 | Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity | Abdel-Aziz, Amal Kamal ; Khaled A M Abouzid ; Minucci, Saverio; Dokla, Eman |
| 6 | 15-Feb-2022 | Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 7 | 2022 | Preclinical activity of fluvastatin-loaded self-nanoemulsifying delivery system against breast cancer models: Emphasis on apoptosis | Elimam, Hanan; Hussein, Jihan; Abdel-Latif, Yasmin; Abdel-Aziz, Amal Kamal ; El-Say, Khalid M |
| 8 | 2022 | Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradication | Moretti, Simona; Abdel-Aziz, Amal Kamal ; Ceccacci, Elena; Pallavicini, Isabella; Santoro, Fabio; de Thé, Hugues; Minucci, Saverio |
| 9 | 2022 | A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer | Abdel-Aziz, Amal Kamal ; Saadeldin, Mona Kamal; Salem, Ahmed Hamed; Ibrahim, Safaa A.; Shouman, Samia; Abdel-Naim, Ashraf B.; Orecchia, Roberto |
| 10 | 1-Dec-2021 | Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; Mahmoud, Amr H.; Saadeldin, Mona Kamal; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 11 | Jan-2021 | Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis | Saadeldin, Mona Kamal; Abdel-Aziz, Amal Kamal ; Abdellatif, Ahmed |
| 12 | 15-Dec-2020 | Novel molecular mechanisms underlying the ameliorative effect of N-acetyl-L-cysteine against ϒ-radiation-induced premature ovarian failure in rats | Mantawy, Eman M.; Said, Riham S.; Kassem, Dina ; Abdel-Aziz, Amal Kamal ; Badr, Amira Mohamed |
| 13 | Jan-2019 | Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: Emphasis on TGF-β/MAPKs signaling pathway | Mantawy, Eman M; Said, Riham S; Abdel-Aziz, Amal Kamal |
| 14 | 2019 | Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside | Abdel-Aziz, Amal Kamal ; Saadeldin, Mona Kamal; D'Amico, Paolo; Orecchioni, Stefania; Bertolini, Francesco; Curigliano, Giuseppe; Minucci, Saverio |
| 15 | 15-Jul-2018 | Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors | Milik, Sandra N; Serya, Rabah ; Minucci, Saverio; Lasheen, Deena S. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
| 16 | Jul-2018 | Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries | El-Agamy, Sara Emad; Sara Abdel Moneim Wahdan ; Esmat, Ahmed; Azab, Samar S; Abdel-Aziz, Amal Kamal |
| 17 | 2018 | Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study | Saadeldin, Mona Kamal; Elshaer, Shereen Saeid; Emara, Ibrahim Ali; Maged, Mohamad; Abdel-Aziz, Amal Kamal |
| 18 | 2017 | Dual modulation of MCL-1 and mTOR determines the response to sunitinib | Elgendy, Mohamed; Renne, Salvatore Lorenzo; Bornaghi, Viviana; Procopio, Giuseppe; Colecchia, Maurizio; Kanesvaran, Ravindran; Toh, Chee Keong; Bossi, Daniela; Pallavicini, Isabella; Perez-Gracia, Jose Luis; Lozano, Maria Dolores; Giandomenico, Valeria; Mercurio, Ciro; Lanfrancone, Luisa; Fazio, Nicola; Nole, Franco; Teh, Bin Tean; Renne, Giuseppe; Minucci, Saverio; Abdel-Aziz, Amal Kamal |
| 19 | 2017 | From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib | Abdel-Aziz, Amal Kamal ; Abdel-Naim, Ashraf B; Shouman, Samia; Minucci, Saverio; Elgendy, Mohamed |
| 20 | 15-Apr-2016 | Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents | Aziz, Marwa A; Serya, Rabah A T; Lasheen, Deena S. ; Mansour, Ahmed M; Ahmed Esmat ; Singab A. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
Loading...
2
0
20
0
false